Enter your Email Address


Useful Links

Know What The Insiders Are Doing!
Stock Trading Software

More Links




[Most Recent Quotes from www.kitco.com]

[Most Recent Quotes from www.kitco.com]




Technical Breakout Alert Issued for CytRx (NASDAQ:CYTR)

Michael Vlaicu (November 23rd, 2009) Writes:

Miv Investments Inc. has initiated an independent bullish technical trading alert for 11/23/09 on CytRx Corporation (NASDAQ:CYTR). Shares of the company finished trading during 11/20/09 at $1.14 per share, up 20.18% from the opening bell on heavy buying pressure. As of 11/18/09, the biopharmaceutical company announced plans to initiate an open-label, multinational Phase 2 clinical trial with its doxorubicin prodrug INNO-206 as a second-line treatment in patients with advanced gastric (stomach) cancer.

CytRx President and CEO Steven A. Kriegsman said, “This planned clinical trial is a key step forward in our plans to build a commercial oncology franchise for CytRx. We have studied the oncology market in solid tumors and believe that stomach cancer represents a major market and an unmet medical problem worldwide. We have also been encouraged by exciting animal data for INNO-206 in a broad array of cancer indications, and

...
More »
Tags for this Post:
2 protocol, Acute Myeloid Leukemia, Alexion Pharmaceuticals Inc;, Am-80, Amgen Inc., APL, bone marrow transplant, Breast Cancer, breast cancers, Celsion Corporation, Chairman, chairman and CEO, Chief Medical Officer, chief scientific officer, chronic myeloid leukemia, CytRx Corporation, Daniel Levitt, director, director of clinical oncology, Discovery Laboratories Inc;, drug development, Europe, European Medicines Agency, Fda, head, Head of Oncology, Hepatocellular carcinoma;, INNO-406, Investing Lessons, Jack R. Barber, Japan, Joseph Rubinfeld, leukemia, leukemias, lung cancers, Max Link, Michael Vlaicu;, MiV Investments Inc., multiple myeloma, myelodysplastic syndrome;, myelodysplastic syndromes, one of the four initial founders, ovarian cancer, Pancreatic Cancer, Philadelphia, president, Protein Design Labs, Sandoz Pharma, Sandoz Pharmaceuticals, sarcoma, STAR-1, Stocks to Watch, The star, treatment for patients with Chronic Myeloid Leukemia, tumor, tumors, United States, USD, who served as president

Posted in Investing Lessons, Stocks to Watch | No Comments »

DrStockPick.com Stock Report! 8/04/09, VSEA, AMOT, SKH, GNBT, IWA, CVG

Dr. Stock Pick (August 4th, 2009) Writes:

DrStockPick.com Stock Report!

Tuesday August 4, 2009

signup3m

**************************************************************

Varian Semiconductor Equipment Associates, Inc. (NASDAQ: VSEA) today announced that the company will deliver a presentation at the 11th Annual Pacific Crest Technology Leadership Forum in Vail, Colorado on Tuesday, August 11, 2009 at 9:30 am mountain time.

Allied Motion Technologies Inc. (NASDAQ: AMOT) today announced it had a net loss for the quarter ended June 30, 2009 of $12,115,000 or $1.60 per diluted share compared to net income of $1,001,000 or $.13 per diluted share for the quarter ended June 30, 2008, a quarter in which the Company achieved record sales and profits. The loss includes a pretax asset impairment charge of $15,986,000 ($11,105,000

...
More »
Tags for this Post:
11th Annual Pacific Crest Technology, Alan L. Wells, Allied Motion Technologies Inc., Amgen Inc., Boston, California, Chairman and Chief Executive Officer, Chief Financial Officer and Treasurer, Chief Scientific Advisor, Colorado, Convergys Corporation, Craig A. Knock, Dr Stock Pick, drug delivery, Generex Biotechnology Corporation, Government Sponsored Enterprises, Holzer Holzer & Fistel LLC, Internet Conference, Iowa Telecom, Iowa Telecommunications Services Inc., Joseph Rubinfeld, leader, loss mitigation services, Market Commentary, Massachusetts, Metabolic Diseases, one of the original founders, Oppenheimer & Co. Inc., relationship management solutions, relationship management;, Skilled Healthcare Group Inc, Sterling Home Retention Services, Stocks to Watch, synthetic vaccine platform technology programs, United States, United States District Court for the Central District o, USD, Vail, Varian Semiconductor Equipment Associates Inc., Vice President, www.generex.com

Posted in Market Commentary, Stocks to Watch | No Comments »


Newsletter

No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.